Search details
1.
Neuroblastoma Patients' Outcome and Chromosomal Instability.
Int J Mol Sci
; 24(21)2023 Oct 24.
Article
in English
| MEDLINE | ID: mdl-37958497
2.
E2F3 gene expression is a potential negative prognostic marker for localised and MYCN not-amplified neuroblastoma: Results of in silico analysis of 786 samples.
Pediatr Blood Cancer
; 69(10): e29800, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35652628
3.
Genomic Analysis Made It Possible to Identify Gene-Driver Alterations Covering the Time Window between Diagnosis of Neuroblastoma 4S and the Progression to Stage 4.
Int J Mol Sci
; 23(12)2022 Jun 10.
Article
in English
| MEDLINE | ID: mdl-35742955
4.
Exosomes from Plasma of Neuroblastoma Patients Contain Doublestranded DNA Reflecting the Mutational Status of Parental Tumor Cells.
Int J Mol Sci
; 22(7)2021 Apr 01.
Article
in English
| MEDLINE | ID: mdl-33915956
5.
Genomic coamplification of CDK4/MDM2/FRS2 is associated with very poor prognosis and atypical clinical features in neuroblastoma patients.
Genes Chromosomes Cancer
; 59(5): 277-285, 2020 05.
Article
in English
| MEDLINE | ID: mdl-31756773
6.
Loss of whole chromosome X predicts prognosis of neuroblastoma patients with numerical genomic profile.
Pediatr Blood Cancer
; 66(5): e27635, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30688024
7.
Role of GOLPH3 and TPX2 in Neuroblastoma DNA Damage Response and Cell Resistance to Chemotherapy.
Int J Mol Sci
; 20(19)2019 Sep 25.
Article
in English
| MEDLINE | ID: mdl-31557970
8.
Telomere shortening and increased oxidative stress are restricted to venous tissue in patients with varicose veins: A merely local disease?
Vasc Med
; 19(2): 125-130, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-24557807
9.
A Simple, Test-Based Method to Control the Overestimation Bias in the Analysis of Potential Prognostic Tumour Markers.
Cancers (Basel)
; 15(4)2023 Feb 13.
Article
in English
| MEDLINE | ID: mdl-36831529
10.
Multiple Genes with Potential Tumor Suppressive Activity Are Present on Chromosome 10q Loss in Neuroblastoma and Are Associated with Poor Prognosis.
Cancers (Basel)
; 15(7)2023 Mar 29.
Article
in English
| MEDLINE | ID: mdl-37046696
11.
Treatment of newborn G6pc(-/-) mice with bone marrow-derived myelomonocytes induces liver repair.
J Hepatol
; 55(6): 1263-71, 2011 Dec.
Article
in English
| MEDLINE | ID: mdl-21703205
12.
Molecular Genetics in Neuroblastoma Prognosis.
Children (Basel)
; 8(6)2021 May 29.
Article
in English
| MEDLINE | ID: mdl-34072462
13.
High Grade of Amplification of Six Regions on Chromosome 2p in a Neuroblastoma Patient with Very Poor Outcome: The Putative New Oncogene TSSC1.
Cancers (Basel)
; 13(22)2021 Nov 18.
Article
in English
| MEDLINE | ID: mdl-34830942
14.
Enhancement of Neuroblastoma NK-Cell-Mediated Lysis through NF-kB p65 Subunit-Induced Expression of FAS and PVR, the Loss of Which Is Associated with Poor Patient Outcome.
Cancers (Basel)
; 13(17)2021 Aug 29.
Article
in English
| MEDLINE | ID: mdl-34503178
15.
Nutlin-3a Enhances Natural Killer Cell-Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors.
Cancer Immunol Res
; 9(2): 170-183, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33303573
16.
The combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cells involve endoplasmic reticulum stress response.
Clin Cancer Res
; 15(4): 1199-209, 2009 Feb 15.
Article
in English
| MEDLINE | ID: mdl-19228726
17.
Roniciclib down-regulates stemness and inhibits cell growth by inducing nucleolar stress in neuroblastoma.
Sci Rep
; 10(1): 12902, 2020 07 31.
Article
in English
| MEDLINE | ID: mdl-32737364
18.
Ezrin interacts with the tumor suppressor CHL1 and promotes neuronal differentiation of human neuroblastoma.
PLoS One
; 15(12): e0244069, 2020.
Article
in English
| MEDLINE | ID: mdl-33326488
19.
The Over-Expression of E2F3 Might Serve as Prognostic Marker for Neuroblastoma Patients with Stage 4S Disease.
Diagnostics (Basel)
; 10(5)2020 05 16.
Article
in English
| MEDLINE | ID: mdl-32429447
20.
Identification of a minimal region of loss on chromosome 6q27 associated with poor survival of high-risk neuroblastoma patients.
Cancer Biol Ther
; 21(5): 391-399, 2020 05 03.
Article
in English
| MEDLINE | ID: mdl-31959052